<DOC>
	<DOCNO>NCT02578082</DOCNO>
	<brief_summary>This multiple-center , nonrandomized , open label , parallel group , single dose study conduct male female subject normal renal function severe ( eGFR &lt; 30 mL/min/1.73 m2 ) renal impairment evaluate effect renal impairment pharmacokinetics ( PK ) TD 4208 .</brief_summary>
	<brief_title>Pharmacokinetics TD-4208 Patients With Severe Renal Impairment</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>For renal impairment group : Subject severe renal impairment ( eGFR &lt; 30 mL/min/1.73 m2 ) For normal renal function group : Subject good health Women pregnant , lactating , breastfeeding , plan become pregnant study . Subject receive investigational drug ( medical device ) within 30 day Subject , reason , deem investigator inappropriate study ; condition would confound interfere evaluation safety , tolerability , PK investigational drug ; unable comply study protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Renal Impairment</keyword>
	<keyword>Renal Insufficiency</keyword>
</DOC>